{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:28:15Z","timestamp":1780471695333,"version":"3.54.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.berh.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T19:28:00Z","timestamp":1519673280000},"page":"517-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Juvenile idiopathic arthritis-associated uveitis"],"prefix":"10.1016","volume":"31","author":[{"given":"Ethan S.","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","article-title":"Uveitis associated with juvenile idiopathic arthritis","volume":"11","author":"Sen","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"14","author":"Clarke","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","article-title":"International uveitis study group. International uveitis study group (IUSG): clinical classification of uveitis","volume":"16","author":"Deschenes","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","article-title":"The pathology and pathogenesis of retinal vasculitis","volume":"29","author":"Hughes","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.berh.2018.01.002_bib6","series-title":"Pediatric Rheumatology \u2013 a clinical viewpoint","first-page":"623","article-title":"Uveitis in children","author":"Sen","year":"2017"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","article-title":"Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature","volume":"244","author":"Carvounis","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"17","key":"10.1016\/j.berh.2018.01.002_bib8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2018.01.002_bib9","article-title":"A\u00a0phase II trial of tocilizumab in anti TNF refractory patients with JIA associated uveitis (APTITUDE study) [Internet]","year":"2015","journal-title":"BioMed Central"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0002-9394(02)02148-7","article-title":"Visual loss associated with pediatric uveitis in English primary and referral centers","volume":"135","author":"Edelsten","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","article-title":"Uveitis in children: population-based study in Finland","volume":"78","author":"Paivonsalo-Hietanen","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bjo.87.7.879","article-title":"Visual loss in uveitis of childhood","volume":"87","author":"de Boer","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0002-9394(03)00314-3","article-title":"Special considerations in the evaluation and management of uveitis in children","volume":"135","author":"Holland","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bjo.2004.050609","article-title":"Uveitis in children and adolescents","volume":"89","author":"BenEzra","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2005.01.044","article-title":"Analysis of pediatric uveitis cases at a tertiary referral center","volume":"112","author":"Kump","year":"2005","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0301-4738.31936","article-title":"Global variation and pattern changes in epidemiology of uveitis","volume":"55","author":"Rathinam","year":"2007","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/09273948.2013.791701","article-title":"Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors","volume":"21","author":"Heiligenhaus","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.berh.2018.01.002_bib18","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3899\/jrheum.130302","article-title":"Risk markers of juvenile idiopathic arthritis-associated uveitis in the childhood arthritis and rheumatology research alliance (CARRA) registry","volume":"40","author":"Angeles-Han","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2018.01.002_bib19","first-page":"461078","article-title":"The role of gender in juvenile idiopathic arthritis-associated uveitis","volume":"2014","author":"Moradi","year":"2014","journal-title":"J\u00a0Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12969-017-0195-8","article-title":"Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study","volume":"15","author":"Nordal","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib21","first-page":"539","article-title":"Course, complications, and outcome of juvenile arthritis-related uveitis","volume":"12","author":"Sabri","year":"2008","journal-title":"J\u00a0AAPOS"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICU.0b013e32833eab83","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"21","author":"Qian","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.berh.2018.01.002_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12969-015-0018-8","article-title":"Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis","volume":"13","author":"Angeles-Han","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.27416","article-title":"Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis","volume":"62","author":"Saurenmann","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0049-0172(87)90019-9","article-title":"Uveitis associated with juvenile rheumatoid arthritis","volume":"16","author":"Rosenberg","year":"1987","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","article-title":"Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bjophthalmol-2011-301023","article-title":"The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty","volume":"96","author":"Hoeve","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/09273941003678837","article-title":"Uveitis related to juvenile idiopathic arthritis: familial cases and possible genetic implication in the pathogenesis","volume":"18","author":"Juli\u00e1n","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2018.01.002_bib29","first-page":"1","article-title":"Pathophysiology of JIA-associated uveitis","author":"Vastert","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.berh.2018.01.002_bib30","first-page":"1394","article-title":"Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis","volume":"18","author":"Giannini","year":"1991","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3476(05)82541-7","article-title":"Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis","volume":"121","author":"Melin-Aldana","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09273940902999356","article-title":"Immune response genes in uveitis","volume":"17","author":"Du","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/eye.2011.255","article-title":"Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation","volume":"26","author":"Lee","year":"2012","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.survophthal.2014.03.002","article-title":"Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown","volume":"59","author":"Kalinina Ayuso","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"10.1016\/j.berh.2018.01.002_bib35","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A\u00a0look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12016-011-8267-x","article-title":"Cutting-edge issues in autoimmune uveitis","volume":"41","author":"Levy","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/jaut.1996.0077","article-title":"Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease","volume":"9","author":"Nussenblatt","year":"1996","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09273948.2012.681830","article-title":"Treg lymphocytes in autoimmune uveitis","volume":"20","author":"Ruggieri","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.22381","article-title":"Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2018.01.002_bib41","first-page":"1074","article-title":"Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue","volume":"16","author":"Uchiyama","year":"1989","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.exer.2007.06.011","article-title":"Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis","volume":"85","author":"Sijssens","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.berh.2018.01.002_bib43","series-title":"Guidelines for screening for uveitis in juvenile idiopathic arthritis","author":"British Society for Paediatric and Adolescent Rheumatology","year":"2006"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"German uveitis in childhood study group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2018.01.002_bib45","series-title":"Best evidence statement (BESt). Screening for uveitis in children with juvenile idiopathic arthritis (JIA)","author":"National Guideline Clearinghouse","year":"2012"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib46","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1542\/peds.2006-0421","article-title":"Section on rheumatology, section on ophthalmology. Ophthalmologic examinations in children with juvenile rheumatoid arthritis","volume":"117","author":"Cassidy","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib47","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/rheumatology\/kep460","article-title":"British society of paediatric and adolescent rheumatology. BSPAR standards of care for children and young people with juvenile idiopathic arthritis","volume":"49","author":"Davies","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib48","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/j.1755-3768.2011.02162.x","article-title":"Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis","volume":"89","author":"Tappeiner","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjophthalmol-2011-300731","article-title":"Elevated intraocular pressure in uveitis associated with juvenile idiopathic arthritis-associated uveitis, often detected after achieving inactivity","volume":"96","author":"Heinz","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.berh.2018.01.002_bib50","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/acr.21674","article-title":"Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood","volume":"64","author":"Heiligenhaus","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib51","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","article-title":"Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus","volume":"35","author":"Bou","year":"2015","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2015.10.005","article-title":"Managing juvenile idiopathic arthritis-associated uveitis","volume":"61","author":"Hawkins","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib53","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.berh.2018.01.002_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11926-014-0437-4","article-title":"Treatment of uveitis associated with juvenile idiopathic arthritis","volume":"16","author":"Bou","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.berh.2018.01.002_bib55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","article-title":"Current therapeutic approaches to autoimmune chronic uveitis in children","volume":"9","author":"Simonini","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib56","first-page":"92","article-title":"Uveitis in juvenile idiopathic arthritis","volume":"112","author":"Heiligenhaus","year":"2015","journal-title":"Deutsches Arzteblatt Int"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate\u2013how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","article-title":"Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach","volume":"52","author":"Simonini","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","article-title":"Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis","volume":"95","author":"Goebel","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","article-title":"Mycophenolate mofetil in the treatment of uveitis in children","volume":"91","author":"Doycheva","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/eye.2011.23","article-title":"Mycophenolate mofetil monotherapy in the management of paediatric uveitis","volume":"25","author":"Chang","year":"2011","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.berh.2018.01.002_bib62","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib63","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/eye.2008.174","article-title":"Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis","volume":"23","author":"Tappeiner","year":"2009","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib64","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","article-title":"Cyclosporin A therapy in refractory non-infectious childhood uveitis","volume":"82","author":"Kilmartin","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib65","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2007.01.026","article-title":"Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis","volume":"114","author":"Hogan","year":"2007","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/archdischild-2013-304396","article-title":"New age of biological therapies in paediatric rheumatology","volume":"99","author":"Sen","year":"2014","journal-title":"Arch Dis Child"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib67","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acr.22214","article-title":"Current evidence of anti-tumor necrosis factor \u03b1 treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs","volume":"66","author":"Simonini","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A\u00a0randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.01.002_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-6215-15-14","article-title":"A\u00a0randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)","volume":"15","author":"Ramanan","year":"2014","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12348-012-0081-y","article-title":"Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis","volume":"2","author":"William","year":"2012","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib71","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3899\/jrheum.120010","article-title":"Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?","volume":"39","author":"Tappeiner","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/09273948.2013.866254","article-title":"Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient","volume":"22","author":"Tsang","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2018.01.002_bib73","series-title":"An open-label trial to assess the efficacy and safety of tocilizumab in the management of juvenile idiopathic arthritis associated vision-threatening uveitis that is refractory to other modes of systemic immunosuppression. ClinicalTrials.gov [Internet]","author":"Suhler","year":"2015"},{"issue":"12","key":"10.1016\/j.berh.2018.01.002_bib74","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3899\/jrheum.160231","article-title":"Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis","volume":"43","author":"Tappeiner","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2018.01.002_bib75","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","article-title":"Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients","volume":"69","author":"Calvo-R\u00edo","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib76","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","article-title":"Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis","volume":"62","author":"Zulian","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00417-010-1523-6","article-title":"Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis","volume":"249","author":"Kenawy","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.berh.2018.01.002_bib78","series-title":"An openlabel, phase II trial of abatacept (orencia) in the treatment of refractory non-infectious uveitis.: ClinicalTrials.gov [Internet]","author":"Suhler","year":"2015"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib79","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","article-title":"Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis","volume":"42","author":"Tappeiner","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2018.01.002_bib80","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.151389","article-title":"Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis","volume":"43","author":"Birolo","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2018.01.002_bib81","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","article-title":"Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)","volume":"50","author":"Heiligenhaus","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ophtha.2010.07.031","article-title":"Rituximab for uveitis","volume":"118","author":"Miserocchi","year":"2011","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib83","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00417-016-3497-5","article-title":"Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis","volume":"255","author":"Breitbach","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib85","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynj\u00e4l\u00e4","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2018.01.002_bib86","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib87","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2006.08.044","article-title":"Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents","volume":"149","author":"Saurenmann","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.berh.2018.01.002_bib88","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2018.01.002_bib89","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.berh.2018.01.002_bib90","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/eye.2009.203","article-title":"Switching biologic agents for uveitis","volume":"23","author":"Dhingra","year":"2009","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/annrheumdis-2013-203523","volume":"73","author":"Burmester","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.01.002_bib92","series-title":"Long-term extension study to evaluate the safety and efficacy of subcutaneous tocilizumab in patients with polyarticular-course and systemic juvenile idiopathic arthritis. ClinicalTrials.gov [Internet]","year":"2017"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib93","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3899\/jrheum.160908","article-title":"Subcutaneous tocilizumab may Be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-associated uveitis","volume":"44","author":"Quesada-Masachs","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2015.04.016","article-title":"Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors","volume":"160","author":"Lerman","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib95","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.161336","article-title":"Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis","volume":"44","author":"Simonini","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib96","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/14740338.2015.1042453","article-title":"Safety of biologic therapies for the treatment of juvenile idiopathic arthritis","volume":"14","author":"Horneff","year":"2015","journal-title":"Expet Opin Drug Saf"},{"issue":"11","key":"10.1016\/j.berh.2018.01.002_bib97","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","article-title":"Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry","volume":"67","author":"Foeldvari","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.berh.2018.01.002_bib98","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/rheumatology\/keu457","article-title":"Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting","volume":"54","author":"Tarkiainen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib99","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.berh.2018.01.002_bib100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09273940802650398","article-title":"Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study","volume":"17","author":"Skarin","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib101","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/ard.2004.026955","article-title":"Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients","volume":"64","author":"Kotaniemi","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib102","doi-asserted-by":"crossref","DOI":"10.2217\/ijr.12.83","article-title":"Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis","volume":"8","author":"Angeles-Han","year":"2013","journal-title":"Int J Clin Rheumtol"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0002-9394(03)00225-3","article-title":"Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program","volume":"135","author":"Chia","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.86.1.51","article-title":"An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood","volume":"86","author":"Edelsten","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.berh.2018.01.002_bib105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ajo.2010.01.014","article-title":"Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis","volume":"149","author":"Kalinina Ayuso","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.berh.2018.01.002_bib106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-3768.2009.01815.x","article-title":"Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis","volume":"90","author":"Zannin","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.berh.2018.01.002_bib107","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00281-014-0433-9","article-title":"Autoimmune and autoinflammatory mechanisms in uveitis","volume":"36","author":"Lee","year":"2014","journal-title":"Semin Immunopathol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:17:20Z","timestamp":1761499040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694218300020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1521694218300020"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2018.01.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile idiopathic arthritis-associated uveitis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}